Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial.

Nardo M, Gouda MA, Reilley MJ, Biter AB, Lim J, Bean SA, Nguyen LM, Bhosale PR, Ager CR, Couillault CA, Piha-Paul SA, Fu S, Tsimberidou AM, Yap TA, Naing A, Rodon J, Subbiah V, Karp DD, Curran MA, Hong DS

Open source

DOI: 10.36401/jipo-24-17
Published: 2025 May
Container: Journal of immunotherapy and precision oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.36401/jipo-24-17,
  title = {Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial.},
  author = {Nardo M and Gouda MA and Reilley MJ and Biter AB and Lim J and Bean SA and Nguyen LM and Bhosale PR and Ager CR and Couillault CA and Piha-Paul SA and Fu S and Tsimberidou AM and Yap TA and Naing A and Rodon J and Subbiah V and Karp DD and Curran MA and Hong DS},
  year = {2025},
  journal = {Journal of immunotherapy and precision oncology},
  doi = {10.36401/jipo-24-17},
  url = {https://doi.org/10.36401/jipo-24-17}
}

RIS

TY  - JOUR
TI  - Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial.
AU  - Nardo M
AU  - Gouda MA
AU  - Reilley MJ
AU  - Biter AB
AU  - Lim J
AU  - Bean SA
AU  - Nguyen LM
AU  - Bhosale PR
AU  - Ager CR
AU  - Couillault CA
AU  - Piha-Paul SA
AU  - Fu S
AU  - Tsimberidou AM
AU  - Yap TA
AU  - Naing A
AU  - Rodon J
AU  - Subbiah V
AU  - Karp DD
AU  - Curran MA
AU  - Hong DS
PY  - 2025
JO  - Journal of immunotherapy and precision oncology
DO  - 10.36401/jipo-24-17
UR  - https://doi.org/10.36401/jipo-24-17
ER  -

APA

M, N., MA, G., MJ, R., AB, B., J, L., SA, B., LM, N., PR, B., CR, A., CA, C., SA, P., S, F., AM, T., TA, Y., A, N., J, R., V, S., DD, K., MA, C., & DS, H. (2025). Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial.. Journal of immunotherapy and precision oncology. https://doi.org/10.36401/jipo-24-17

Source records

pubmed · retrieved 2026-09-27T12:02:25.951Z